“Award Winning Alerts”
Click above to visit: Wolf Of Penny Stocks
Donate To Hereitfirst!
Stock Market News Feed- Why it's time for investors to go on defense October 4, 2018
- Premarket: 7 things to know before the bell October 4, 2018
- Barnes & Noble stock soars 20% as it explores a sale October 3, 2018
- Toys 'R' Us brand may be brought back to life October 3, 2018
- Honda teams up with GM on self-driving cars October 3, 2018
Tag Archives: diabetes
Market Recap April Fools, Stock Picks for 3-2
Today was a great day but before we begin with our usual post I would like to get a point across to our fan base/ followers. Anyone who has made money from our advice and stock picks we do not … Continue reading
Posted in stock market
Tagged afrezza, diabetes, FDA approval, legalization, marijuana, marijuanastocks, mnkd, phot
Leave a comment
MannKind Corp. (MNKD) receives an “okay” from the FDA
After-hours today MannKind Corp. got a verbal “yes” from the FDA on their inhaled diabetes treatment, Afrezza. FDA approved advisors voted positively for the MNKD drug. Afrezza received a 13 to 1 vote for the drug to be used to … Continue reading
Posted in stock market, Uncategorized
Tagged afrezza, breakthrough, diabetes, fda, FDA staff, mankind, mannkind, MannKind Corp., medicine, mnkd, pharma, pharma stock, Pharmaceuticals, research, science, stock, stockmarket, Type 1 diabetes, Type 2 diabetes
1 Comment
Afrezza’s Outlook on April 1st
As you all may already know shares of MNKD were halted ahead of the AdCom. At Hereitfirst we have been monitoring for the last 4 months. We have come to believe that MNKD will almost certainly be approved for Type … Continue reading
Posted in stock market
Tagged adcom, afrezza, afrezza approval, diabetes, FDA approval, health care, inhalable insulin, mannkind, medicine, mnkd, type 2, type1
6 Comments
Post Briefing Analysis On MNKD
MNKD had a roller coaster day as they stormed right out of the gate with highs of 5.75 ( Up 9% ) before closing at 4.83 ( down 7%). This could be attributed to the fact that good news came … Continue reading
Posted in stock market
Tagged afrezza, approval, briefing, diabetes, doctors, FDA approval, healthcare, insulin, mannkind, mannkind approval, medicine, mnkd
7 Comments
